Michael Partridge | SVP of IR |
Reshma Kewalramani | CEO, President and Director |
Stuart Arbuckle | Executive VP and COO |
Charles Wagner | Executive VP and CFO |
Bastiano Sanna | Executive VP, Chief of Cell and Genetic Therapies and VCGT Site Head |
David Altshuler | Executive VP of Global Research and Chief Scientific Officer |
Cory Kasimov | JPMorgan |
Jason Zemansky | BofA |
Robyn Karnauskas | Truist Securities |
Salveen Richter | Goldman Sachs |
Michael Yee | Jefferies |
Phil Nadeau | Cowen & Company |
Colin Bristow | UBS |
Mohit Bansal | Wells Fargo |
Evan Seigerman | BMO Capital Markets |
Liisa Bayko | Evercore ISI |
Good evening. This is Michael Partridge. Welcome to Vertex's First Quarter 2022 Financial Results Conference Call. On tonight's call, making prepared remarks, we have Dr. Reshma Kewalramani, Vertex's CEO and President; Stuart Arbuckle, Chief Operating Officer; and Charlie Wagner, Chief Financial Officer; Dr.